21:17 , Aug 12, 2019 |  BC Extra  |  Financial News

AstronauTx launches to target astrocytes for Alzheimer's

AstronauTx is looking to go beyond the amyloid/tau paradigm in Alzheimer's disease with £6.5 million ($7.8 million) in seed capital to develop therapies that modulate astrocyte function. The newco raised the capital from the Dementia...